Next, the role of PI3K/Akt/GSK-3β signaling pathway in the integrity of BBB was further investigated using the following antagonists: PI3K inhibitor wortmannin and GSK-3β siRNA in the model of warfarin-associated HT after cerebral ischemia. This evidence concerns the gene AKT1 and hematocrit.